 | 10/28/2009 | Canakinumab Approved in EU for Patients 4 Years and Older With Cryopyrin-Associated Periodic Syndromes - (DGNews) |
| 10/25/2009 | Canakinumab Gives Faster, Greater Pain Relief in Refractory Gout Patients: Presented at ACR/ARHP - (DGDispatch) |
| 10/25/2009 | Previous Urate-Lowering Therapy Plus Febuxostat Lowers Urate Levels, Number of Flares in Patients With Gout: Presented at ACR/ARHP - (DGDispatch) |
| 10/19/2009 | Canakinumab Therapy Shows Promise for Systemic Juvenile Idiopathic Arthritis: Presented at AAP - (DGDispatch) |
| 10/12/2009 | New Interleukin-12/23 Monoclonal Antibody Effective Against Moderate to Severe Psoriasis: Presented at EADV - (DGDispatch) |
| 07/03/2009 | Gene Expression Findings May Help Classify, Predict, and Treat Juvenile Arthritis - (DGNews) |
| 06/16/2009 | Golimumab Shows Sustained Efficacy in Ankylosing Spondylitis Over 104 Weeks: Presented at EULAR - (DGDispatch) |
| 06/15/2009 | Golimubab Shows Long-Term Efficacy in Treatment of Psoriatic Arthritis: Presented at EULAR - (DGDispatch) |
| 04/24/2009 | FDA Approves Golimumab for Treating 3 Types of Immune-Related Arthritis - (DGNews) |
| 04/13/2009 | Golimumab Approved for Psoriatic Arthritis, Ankylosing Spondylitis, and RA in Canada - (DGNews) |
| 04/07/2009 | Golimumab Significantly Improves Active Psoriatic Arthritis, Nail Psoriasis - (DGNews) |
| 03/09/2009 | Vitamin C Intake Associated With Lower Risk of Gout in Men - (DGNews) |
| 02/11/2009 | Ustekinumab Reduces Symptoms of Psoriatic Arthritis, Diminishes Skin Lesions - (DGNews) |
| 12/17/2008 | NICE Issues Guidance on the Use of Febuxostat for Hyperuricaemia - (DGNews) |
| 10/29/2008 | Efficacy and Safety of Golimumab Treatment Maintained at 52 Weeks in Patients With Psoriatic Arthritis: Reported at ACR-ARHP - (DGDispatch) |
| 10/16/2008 | FDA Approves Labeling Changes, Boxed Warning for Efalizumab - (DGNews) |
| 07/22/2008 | New ACR Guidelines Update Strategies for Treating RA - (DGNews) |
| 07/14/2008 | Abatacept Improves Juvenile Idiopathic Arthritis in Randomised Withdrawal Trial, but Study Design Questioned - (DGNews) |
| 06/15/2008 | Zoledronic Acid Better for Bone Remodelling Than Risedronate in Glucocorticoid-Induced Osteoporosis: Presented at EULAR - (DGDispatch) |
| 06/15/2008 | Adalimumab Demonstrates Long-Term Benefit in Ankylosing Spondylitis: Presented at EULAR - (DGDispatch) |
| 06/15/2008 | Infliximab Monotherapy Effective for Long-Term Treatment of Spondyloarthritis: Presented at EULAR - (DGDispatch) |
| 06/14/2008 | Malignancies in Etanercept-Treated Patients Uncommon: Presented at EULAR - (DGDispatch) |
| 06/13/2008 | Teriparatide Tops Alendronate in Multiple Subgroups at Increased Fracture Risk: Presented at EULAR - (DGDispatch) |
| 06/13/2008 | Adalimumab Effective in Patients With Rheumatic Disease Unresponsive to Other Anti-TNF Therapies - (DGNews) |
| 05/29/2008 | Oral Prednisolone and Naproxen Found Equally Beneficial in the Treatment of Gout Arthritis - (DGNews) |
| 05/09/2008 | Diclofenac Epolamine Topical Patch Efficacious and Safe in Elderly Patients With Acute Periarthritis: Presented at AGS - (DGDispatch) |
| 05/08/2008 | Novel Urate-Lowering Agent, Febuxostat, Shows Better Results in Older Adults With Gout Compared With Allopurinol: Presented at AGS - (DGDispatch) |
| 05/06/2008 | Febuxostat Approved in Europe for the Treatment of Chronic Hyperuricaemia in Patients With Gout - (DGNews) |
| 04/17/2008 | Tocilizumab Approved in Japan for the Treatment of Rheumatoid Arthritis - (DGNews) |
| 04/08/2008 | FDA Approves Abatacept for the Treatment of Polyarticular Juvenile Idiopathic Arthritis - (DGNews) |